بر اساس عنوان

1
Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting
2
Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting
3
Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function
4
Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse
5
Hepatitis C NS3 helicase unwinds RNA in leaps and bounds
6
Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure
7
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives
8
Hepatitis C outbreak astounds Spain
9
Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population
10
Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population
11
Hepatitis C Rapid Point-of-Care Testing and Laboratory-based Non-invasive Assessment of Liver Fibrosis among Drug Abusers: An Experience from Iran
12
Hepatitis C seropositivity in patients with acute and chronic urticaria
13
Hepatitis C seroprevalence among intravenous drug users in Tehran
14
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system
15
Hepatitis C therapy in treatment-naïve patients
16
Hepatitis C transmission associated with intravenous immunoglobulins
17
Hepatitis C transmission by cosmetic tattooing in women
18
Hepatitis C Treatment Among People Who Use Drugs in an Office-Based Opioid Treatment Program Versus a Syringe Exchange Program: A Real-World Prospective Clinical Trial
19
Hepatitis C treatment update
20
Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan
21
Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules
22
Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin
23
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy
24
Hepatitis C viral life cycle
25
Hepatitis C virus
26
Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents
27
Hepatitis C Virus (HCV) “A Possible Independent Risk Factor” for Coronary Artery Disease
28
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells
29
Hepatitis C virus (HCV) genotype 1B infection is associated with a high incidence of graft cirrhosis after liver transplantation (OLT)
30
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
31
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection
32
Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan
33
Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction
34
Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital
35
Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection
36
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia
37
Hepatitis C virus (HCV)-infection and oral lichen planus
38
Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
39
Hepatitis C virus and blood transfusion: past and present risks
40
Hepatitis C virus and hepatocellular carcinoma
41
Hepatitis c virus and human immunodeficiency virus: clinical issues in coinfection
42
Hepatitis C Virus and Human Immunodeficiency Virus-I (HIV) Co-Infection in Children in Benin City, Nigeria.
43
Hepatitis C virus and kidney disease
44
Hepatitis C Virus and Lichen Planus: The Real Association
45
Hepatitis C virus and liver steatosis: when fat is not beautiful
46
Hepatitis C Virus and Vaccine Development
47
Hepatitis C Virus Antibodies and Vitiligo Disease
48
Hepatitis C Virus Antibody Positive Cases in Multitransfused Thalassemic Patients in South of Iran
49
Hepatitis C virus antibody, viral RNA and genotypes in leprous patients in Japan
50
Hepatitis C Virus as a Multifaceted Disease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection
51
Hepatitis C virus assembly: When fat makes it easier
52
Hepatitis C Virus Capsid Protein and Intracellular Lipids Interplay and Its Association With Hepatic Steatosis
53
Hepatitis C virus challenges AIDS associated viruses at the transfusion crossings: the place and time for a second trial
54
Hepatitis C virus clearance improves quality of life
55
Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin
56
Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals
57
Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b
58
Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression
59
Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes
60
Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
61
Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation
62
Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation
63
Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2
64
Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation
65
Hepatitis C Virus Core Protein: An Update on Its Molecular Biology, Cellular Functions and Clinical Implications
66
Hepatitis C Virus Cryoglobulinemia and non-Hodgkin Lymphoma
67
Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients
68
Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein
69
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
70
Hepatitis C virus genetic variability in patients undergoing antiviral therapy
71
Hepatitis C virus genotype 1 associated with massive steatosis of the liver and hypo-β-lipoproteinemia
72
Hepatitis C Virus Genotype Distribution in Shiraz, Southern Iran
73
Hepatitis C Virus Genotypes and Association With Viral Load in Yazd, Central Province of Iran
74
Hepatitis C virus genotypes and quasispecies
75
Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia
76
HEPATITIS C VIRUS GENOTYPES IN A NORTHEASTERN AREA OF BRAZIL
77
Hepatitis C virus genotypes in Adana and Antakya regions of Turkey
78
HEPATITIS C VIRUS GENOTYPES IN BAHAWALPUR
79
Hepatitis C virus genotypes in elderly patients with chronic hepatitis C
80
HEPATITIS C VIRUS GENOTYPES IN IRAQ
81
Hepatitis C Virus Genotypes in Patients Referred to Educational Hospitals in Zahedan (2009 ‒ 2013)
82
Hepatitis C virus Genotypes in Patients with End-Stage Renal Disease in East Azerbaijan, Iran
83
Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples
84
Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azerbaijan, Northwest of Iran
85
Hepatitis C virus in blood donation
86
Hepatitis C virus in breast milk
87
Hepatitis C virus in elderly patients with chronic liver diseases
88
HEPATITIS C VIRUS IN IRAN: EPIDEMIOLOGY OF AN EMERGING INFECTION
89
Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes
90
Hepatitis C Virus in North Africa: An Emerging Threat
91
Hepatitis C virus in people with HIV infection
92
Hepatitis C virus in people with HIV infection
93
Hepatitis C virus in saliva of haemophiliac patients attending an oral surgery unit
94
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
95
Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy
96
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk
97
Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran
98
Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt
99
Hepatitis C virus infection among patients on hemodialysis: A report from a single center in Iran
100
Hepatitis C Virus Infection among Teaching Hospital Patients in Kano, Nigeria: A Retrospective Study
101
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town
102
Hepatitis C virus infection and autoimmune thrombocytopenic purpura
103
Hepatitis C Virus Infection and Chronic Obstructive Pulmonary Disease
104
Hepatitis C virus infection and cryoglobulinemia
105
Hepatitis C virus infection and genotypes in blood donors
106
Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
107
Hepatitis C Virus Infection and Kidney Transplantation A Review for Clinicians
108
Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France
109
Hepatitis C virus infection and primary Sjögrenʹs Syndrome: A clinical and serologic description of 9 patients
110
Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt
111
Hepatitis C Virus Infection Complicated by Kidney Disease
112
Hepatitis C Virus Infection in Blood Donors: An Emerging Risk to Transfusion Services
113
Hepatitis C virus infection in children
114
Hepatitis C virus infection in dialysis centers of Tabriz, Iran: a multicenter study
115
Hepatitis C virus infection in dialysis patients
116
Hepatitis C virus infection in Eastern Europe
117
Hepatitis C virus infection in hemodialysis patients in Sudan: Two centers report
118
Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures
119
Hepatitis C Virus Infection in Isfahan, Iran: A Review Article
120
Hepatitis C virus infection in nephrology patients
121
Hepatitis C Virus Infection in Non-Hodgkin’s Lymphoma: A Case-ControlStudy
122
HEPATITIS C VIRUS INFECTION IN PATIENTS ON LONG TERM HEMODIALYSIS
123
Hepatitis C Virus Infection in Patients with Hemophilia in Isfahan, Iran
124
Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication
125
Hepatitis C virus infection in special groups
126
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis
127
Hepatitis C virus infection in the United States
128
Hepatitis C virus infection in Western Europe
129
Hepatitis C virus infection manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis
130
Hepatitis C virus infection of salivary gland epithelial cells : Lack of evidence
131
Hepatitis C Virus Infection Trends in Italy
132
Hepatitis C Virus Infection Trends in Italy, 1996–2006
133
Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction
134
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?
135
Hepatitis C virus infection, tuberculosis, and sexually transmitted diseases
136
Hepatitis C virus infection: co-infection with HIV and HBV
137
Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in I.R. IRAN
138
Hepatitis C virus infection: quality of life and side effects of treatment
139
Hepatitis C virus infection: when silence is deception
140
Hepatitis C virus infection-associated non-cryoglobulinaemic monoclonal IgMκ gammopathy responsive to interferon-α treatment
141
Hepatitis C Virus Load in Seropositive Liver and Kidney Transplant Recipients by Quantitative Real-Time PCR Before and After Transplantation
142
Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture
143
Hepatitis C virus NS3 NTPase/Helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step
144
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety Original Research Article
145
Hepatitis C Virus NS3 Protease Requires Its NS4A Cofactor Peptide for Optimal Binding of a Boronic Acid Inhibitor as Shown by NMR Original Research Article
146
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding
147
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of moiety with improved potency
148
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034
149
Hepatitis C virus NS3-4A serine protease inhibitors: Use of a P2–P1 cyclopropyl alanine combination for improved potency
150
Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death
151
Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt
152
Hepatitis C Virus RNA (HCV-RNA) in Blood Donors and Family Members Seropositive for Anti-HCV Antibodies
153
Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L
154
Hepatitis C virus RNAs replicating in cell culture
155
Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department
156
Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity
157
Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran
158
Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine
159
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
160
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
161
Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA
162
Hepatitis C virus transmission by intravenous immunoglobulin
163
Hepatitis C virus transmission by monoclonal- purified viral-attenuated factor VIII concentrate
164
Hepatitis C Virus Treatment Revolution: Eastern European Story
165
Hepatitis C Virus Treatment with Sofosbuvir Plus Ribavirin Regimen in Khuzestan Province
166
Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes
167
Hepatitis C virus ultrastructure and morphogenesis.
168
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients
169
Hepatitis C virus, rheumatoid factors, and disease progression
170
Hepatitis C virus, Sjögrenʹs syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer
171
Hepatitis C Virus. Current Studies in Hematology and Blood Transfusion : Edited by Harvey Reesink, 212, S. Karger AG, Basel, DM 290, ISBN 3-8055-5866-X
172
Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, November 2011, Tehran, Iran
173
Hepatitis C Virus; Its Implication for Endodontists
174
Hepatitis C virus-related arthritis
175
Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C
176
Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy
177
Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level in Healthy, Anti-HCV-Negative Individuals
178
Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women
179
Hepatitis C with and without dermatological manifestations: comparison of human leukocyte antigen-DR types, circulating T-cell subsets, and relation to disease severity
180
Hepatitis C, ,
181
Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions
182
Hepatitis C. Biomedical Research Reports: T. Jake Liang and Jay H. Hoofnagle (Eds.), Academic Press, 2000, ISBN 0-12-447870-0, $99.95
183
HEPATITIS C: A COMMON BUT INFREQUENTLY TREATED DISEASE
184
HEPATITIS C: A LEADING CAUSE OF CIRRHOSIS AT DHQ HOSPITAL D.I.KHAN
185
Hepatitis C: molecular virology and antiviral targets
186
Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia
187
Hepatitis C: public health strategies
188
Hepatitis C: the clinical spectrum of the disease
189
Hepatitis C: the dermatologic profile
190
Hepatitis C-Associated Chronic Lymphoproliferative Disorders: A Single Center Experience
191
Hepatitis C-Associated Osteosclerosis After Blood Transfusion
192
Hepatitis C-Associated Osteosclerosis: An Unusual Syndrome of Acquired Osteosclerosis in Adults
193
Hepatitis C—virology and future antiviral targets
194
Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin
195
Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme levels and Histopathology-an Epidemiological Study in Shiraz, Southern Iran, 2003-2004
196
Hepatitis D Is a Forgotten Problem in Hemodialysis Patients in the World
197
Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in “Isolated anti-HBc” Antibodies Profile in Central Tunisia
198
Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
199
Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections
200
Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia)
201
Hepatitis disease diagnosis using a new hybrid system based on feature selection (FS) and artificial immune recognition system with fuzzy resource allocation
202
Hepatitis DVirus Infection among HIV-HBV Co-Infected Patients in Kermanshah, West of Iran
203
Hepatitis E antibodies and HIV status
204
Hepatitis E associated with surgical training on pigs
205
Hepatitis E in Brazil
206
HEPATITIS E SEROCONVERSION IN UNITED STATES TRAVELERS ABROAD
207
Hepatitis E Virus
208
Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death
209
Hepatitis E virus and HIV infection in homosexual men
210
Hepatitis E virus and pigs: A zoonotic risk in Europe?
211
Hepatitis E Virus and Renal Transplantation
212
Hepatitis E virus and serum level aminotransferases in blood donors
213
Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis
214
Hepatitis E virus genotyping based on full-length genome and partial genomic regions
215
Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants
216
Hepatitis E virus infection
217
Hepatitis E Virus Infection Among Chronic Hemodialysis
218
Hepatitis E Virus Infection Among Iranian Patients with Beta-Thalassemia
219
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis
220
Hepatitis E Virus Infection in a Northern Mexican City: A Cross-Sectional Seroprevalence Study
221
Hepatitis E Virus Infection in Hemodialysis Patients: A Seroepidemiological Survey in Jahrom, Southern Iran
222
Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients
223
Hepatitis E Virus Infection in Macaca Mulatta
224
Hepatitis E Virus Infection: A Neglected Problem in Our Region
225
Hepatitis E virus load in swine organs and tissues at slaughterhouse determined by real-time RT-PCR
226
Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran
227
Hepatitis E Virus Seroprevalence Among Liver Transplant Recipients with Persistent Elevation of Liver Enzymes: A Single Center Report
228
Hepatitis E Virus Seroprevalence and Viremia in Hemodialysis and HIV Infected Patients in Iran
229
Hepatitis E virus seroprevalence in haemodialysis patients in Zanjan province, Islamic Republic of Iran
230
Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran
231
Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate
232
Hepatitis E: a virus in waiting
233
Hepatitis E: An emerging awareness of an old disease
234
Hepatitis E: Risk and Prevention
235
Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection
236
Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection
237
Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan‑Iran
238
Hepatitis G virus in immunosuppressed paediatric allograft recipients
239
Hepatitis G virus in India
240
Hepatitis G virus in Karachi, Pakistan
241
Hepatitis G virus in long-term survivors of haematological malignancy
242
Hepatitis G virus infection
243
Hepatitis G virus infection
244
Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy
245
Hepatitis G Virus Infection in Iranian Blood Donors and High-Risk Groups
246
Hepatitis G-associated aplastic anaemia
247
Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany
248
Hepatitis in Ontario linked to EEG electrodes
249
Hepatitis induced by Kava (Piper methysticum rhizoma)
250
Hepatitis meeting suggests end of “carrier” status
251
Hepatitis Monthly, an International Journal in the Field of Hepatology
252
Hepatitis patients lost to follow-up at a liver centre in a tertiary care hospital of Karachi, Pakistan — a cross-sectional descriptive study
253
Hepatitis treatment in developing countries
254
Hepatitis treatment moves on
255
Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma
256
Hepatitis virus infection and atherosclerosis: reply to Vassalle, Zucchelli and Giustini
257
Hepatitis Virus Infection and Hodgkin s Lymphoma: A Review of the Literature
258
Hepatitis virus infections in heart transplant recipients
259
Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment
260
Hepatitis viruses and the MAPK pathway: is this a survival strategy?
261
Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes
262
Hepatitis viruses in the XXI century
263
Hepatitis: A Rapidly Spreading Viral Infection in Pakistan
264
Hepatitis-B vaccine down under
265
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
266
Hepatitis-C and Hepatitis-B Co-Infections in Patients with Human Immunodeficiency Virus in Tehran, Iran
267
Hepatitis-C Infection Incidence Among the non-Hodgkin’s B-cell Lymphoma Patients in the Northeast of Iran
268
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
269
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
270
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
271
Hepatitis-C-virus risk from Italian fertility centre
272
Hepatitis-E-associated fulminant hepatic failure in non-pregnant young women
273
Hepato- and Reno-Protective Impacts of Plantago major: An Experimental Model of Testicular Ischemia/Reperfusion
274
Hepato Protective and Antioxidant Role of Berberis tinctoria Lesch Leaves on Paracetamol Induced Hepatic Damage in Rats
275
Hepatoadrenal syndrome in Egyptian children with liver cirrhosis with and without sepsis
276
Hepatoatrial anastomosis and tricuspid valve replacement in budd-chiari syndrome 8.
277
Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis
278
Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
279
Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen
280
Hepatobiliary Cystadenoma Mimicking Liver Hydatid Cyst
281
Hepatobiliary Cystadenoma with Mesenchymal Stroma Mistaken for Common Bile Duct Stone
282
Hepatobiliary excretion and brain distribution of caffeine in rats using microdialysis Original Research Article
283
Hepatobiliary excretion of 99mTc-EC: A potential source of mistake in the interpretation of renal scintigraphy
284
Hepatobiliary Excretion of Dipyrrinone Sulfonates in Mrp2-Deficient (TR−) Rats
285
Hepatobiliary Fascioliasis: Clinical and Radiological Features
286
Hepatobiliary Involvement in Neonates With COVID-19 Infection: A Narrative Review
287
Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride
288
Hepatobiliary scintigraphy: An effective tool in the management of bile leak following laparoscopic cholecystectomy
289
Hepatobiliary surgeons meet immunologists: the case of colorectal liver metastases patients
290
Hepatobiliary surgery
291
HepatoBiliary Surgery and Nutrition - Message from the Editor-in-Chief
292
Hepatobiliary Surgery and Nutrition is indexed by SCIE: a tremendous step forward
293
Hepatobiliary surgery: the past, present, and future learned from Professor Henri Bismuth
294
Hepatobiliary transport
295
Hepatobiliary, renal and bone complications of intestinal failure
296
Hepatoblastoma in a 2-year-old child of a liver-transplanted mother
297
Hepatoblastoma in a patient with a partial trisomy 9p syndrome: a case report
298
Hepatoblastoma Related Tumor Thrombosis Extended to IVC, Ra and Pulmonary Artery Branches: A Case Report
299
Hepatoblastomas in Oman
300
Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
301
Hepatocarcinogenesis: A polygenic model of inherited predisposition to cancer
302
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
303
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
304
Hepatocellular adenoma displaying a HNF1α inactivation in a patient with familial adenomatous polyposis coli
305
Hepatocellular adenomas in patients taking danazol for here ditary angiooedema
306
Hepatocellular Cancer: A Guide for the Internist
307
Hepatocellular carcinoma
308
Hepatocellular carcinoma
309
Hepatocellular carcinoma
310
Hepatocellular carcinoma
311
Hepatocellular carcinoma
312
Hepatocellular carcinoma
313
Hepatocellular carcinoma
314
Hepatocellular carcinoma
315
Hepatocellular carcinoma (HCC) recurrence and what to do when it happens
316
Hepatocellular carcinoma after radiofrequency ablation therapy: Dynamic CT evaluation of treatment
317
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol
318
Hepatocellular Carcinoma and Academic Skills Workshop cosponsored by Hepatobiliary Surgery and Nutrition and AME Publishing Company
319
Hepatocellular carcinoma and extrahepatic primary malignancy
320
Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran
321
Hepatocellular carcinoma and the art of prognostication
322
Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?
323
Hepatocellular carcinoma development in cirrhosis
324
Hepatocellular Carcinoma Diagnosis Based on Ultrasound Images Using Feature Selection Techniques and K-nearest Neighbor Classifier
325
Hepatocellular carcinoma from diagnosis to treatment: 15 years of challenges and modification of resection strategies
326
Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report
327
Hepatocellular Carcinoma in a non-B non-C Non-alcoholic Steatohepatitis (NBNC-NASH HCC)
328
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal α-fetoprotein
329
Hepatocellular carcinoma in a young survivor of major burns
330
Hepatocellular carcinoma in alcoholics
331
Hepatocellular Carcinoma in Dog – Case Report
332
HEPATOCELLULAR CARCINOMA IN EGYPTIANS WITH AND WITHOUT A HISTORY OF HEPATITIS B VIRUS INFECTION: ASSOCIATION WITH HEPATITIS C VIRUS (HCV) INFECTION BUT NOT WITH HCV RNA LEVEL
333
Hepatocellular Carcinoma in Explanted Livers of Patients with Genotype D HBV Cirrhosis: Report of the First Experience from Iran
334
Hepatocellular Carcinoma in Pakistan: Where do We Stand?
335
Hepatocellular carcinoma in patients suffering from primary sclerosing cholangitis
336
Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors
337
Hepatocellular carcinoma in patients with HCV
338
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
339
Hepatocellular Carcinoma in Port Harcourt, Nigeria: Clinicopathologic Study of 75 Cases
340
Hepatocellular Carcinoma in Pregnancy with Unusual Presentations
341
Hepatocellular Carcinoma in Sheep.
342
Hepatocellular Carcinoma in Sheep.
343
Hepatocellular carcinoma in situs inversus totalis-a case report
344
Hepatocellular Carcinoma in the World and the Middle East
345
Hepatocellular Carcinoma in Two Patients with Autoimmune Hepatitis, A Single Center Experience and Review of the Literature
346
Hepatocellular Carcinoma is an Emerging Issue Now in Iran
347
Hepatocellular carcinoma markers in the omics era: the glycomic analysis
348
Hepatocellular carcinoma on the increase in USA
349
Hepatocellular carcinoma with disseminated skeletal muscle metastasis
350
Hepatocellular carcinoma with extension into the right atrium
351
Hepatocellular Carcinoma With Intracavitary Cardiac Involvement: A Case Report and Review of the Literature
352
Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation
353
Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM
354
Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy
355
Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver
356
Hepatocellular Carcinoma: A Pledge for Evidence-based Medicine
357
Hepatocellular carcinoma: an entity needed to be differentiated
358
Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit
359
Hepatocellular Carcinoma: An Update
360
Hepatocellular carcinoma: beyond screening
361
Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Review
362
Hepatocellular Carcinoma: First Manifestation as SolitaryHumeral Bone Metastasis
363
Hepatocellular Carcinoma: From Molecular Basis to Novel Treatment Approaches
364
Hepatocellular carcinoma: present status and future prospects
365
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
366
Hepatocellular Damage and Severity of COVID-19 Infection in Iraqi Patients: A Biochemical Study
367
Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective
368
Hepatocellular functions of human liver cells in oxygen-permeable membrane device Original Research Article
369
Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity
370
Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide
371
Hepatocellular oxidative stress and initial graft injury in human liver transplantation
372
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
373
Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury
374
Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?
375
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: kinetic evidence for a high affinity/low capacity sinusoidal membrane system
376
HepatoConsult: a knowledge-based second opinion and documentation system
377
Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata
378
Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins
379
Hepatocyte and Islet Cell Cotransplantation on Poly-L-Lactide Matrix for the Treatment of Liver Cirrhosis
380
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
381
Hepatocyte behavior on synthetic glycopolymer matrix: inhibitory effect of receptor–ligand binding on hepatocyte spreading
382
Hepatocyte culture on carbohydrate-modified star polyethylene oxide hydrogels
383
Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces
384
Hepatocyte growth factor (HGF)-induced activation of the AP-1 complex : a comparison between normal and transformed rat hepatocytes
385
Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis
386
Hepatocyte growth factor activates the AP-1 complex: a comparison between normal and transformed rat hepatocytes
387
Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer
388
Hepatocyte growth factor and its actions in growth plate chondrocytes
389
Hepatocyte growth factor and placental development
390
Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease
391
Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
392
Hepatocyte growth factor in gingival crevicular fluid and the distribution of hepatocyte growth factor-activator in gingival tissue from adult periodontitis
393
Hepatocyte growth factor in human amniotic fluid promotes the migration of fetal small intestinal epithelial cells, ,
394
Hepatocyte growth factor induces activation of Nck and phospholipase C-γ in lung carcinoma cells
395
Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line
396
Hepatocyte growth factor inhibits insulin-stimulated glycogen synthesis in primary cultured hepatocytes
397
Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques
398
Hepatocyte growth factor level in the vitreou of patient with proliferative vitreoretinopathy
399
Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1α, and stem cell factor
400
Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis
401
Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis
402
Hepatocyte Growth Factor Regulation of Uterine Epithelial Cell Transepithelial Resistance and Tumor Necrosis Factor (alpha)Release in Culture
403
Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues
404
Hepatocyte growth factor/scatter factor, angiogenesis and tumour cell proliferation in primary breast cancer
405
Hepatocyte growth factor: a multifunctional cytokine
406
Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-κB
407
Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
408
Hepatocyte Isolation From Unused/Rejected Livers for Transplantation: Initial Step Toward Hepatocyte Transplantation, the First Experience From Iran
409
Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
410
Hepatocyte nuclear factor (HNF)-4α/γ, HNF-1α, and vHNF-1 regulate the cell-specific expression of the human dihydrodiol dehydrogenase (DD)4/AKR1C4 gene
411
Hepatocyte Nuclear Factor 1 α Controls Renal Expression of the Npt1-Npt4 Anionic Transporter Locus
412
Hepatocyte Nuclear Factor 4 Alpha Ligand Binding and F Domains Mediate Interaction and Transcriptional Synergy with the Pancreatic Islet LIM HD Transcription Factor Isl1
413
Hepatocyte Nuclear Factor 4 Is a Transcription Factor that Constitutively Binds Fatty Acids
414
Hepatocyte Nuclear Factor 4-Mediated Activation of Rat CYP3A1 Gene and Its Modes of Modulation by Apolipoprotein AI Regulatory Protein I and v-ErbA-Related Protein 3
415
Hepatocyte nuclear factor-4α plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver
416
Hepatocyte performance on different crystallographic faces of rutile
417
Hepatocyte Polyploidy and Metabolism/Life-history Traits: Hypotheses Testing
418
Hepatocyte proliferation – can we target the mechanism?
419
Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis
420
Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling
421
Hepatocyte proliferative activity in human liver cirrhosis
422
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
423
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a
424
Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies
425
Hepatocyte vacuolation and autolytic changes in the liver of pilot whales, Globicephala melas, stranded on Cape Cod, MA, USA
426
Hepatocyte-Derived MicroRNAS as Serum Predictors of Rejection of Liver Transplantation
427
Hepatocytes as a source of collagen type XVIII endostatin
428
Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells
429
Hepatocyte-supported serum-free culture of rat liver sinusoidal endothelial cells
430
Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature
431
Hepatoid carcinoma of the pancreas mimicking neuroendocrine tumor
432
Hepatoid Variant of Yolk Sac Tumor of Both Ovaries With Widespread Intraabdominal and Lung Metastasis: A Case Report
433
Hepatologie : Edited by Gerok/Blum, 942, Urban & Schwarzenberg, US $ 398, ISBN 3-541-12272-2
434
Hepatology may have problems with putative surrogate outcome measures
435
Hepatoma-derived Growth Factor Represses SET and MYND Domain Containing 1 Gene Expression through Interaction with C-terminal Binding Protein
436
Hepatomegaly: A Major Clinical Sign in Some Metabolic Disorders
437
Hepatopancreas mitochondria of Mytilus galloprovincialis: effect of zinc ions on mitochondrial bioenergetics and metabolism
438
Hepatopancreatic nuclease of black tiger shrimp Penaeus monodon unlikely to be involved in viral triggered apoptosis
439
Hepatopathy and Reno-cardiopathy Induced by Ritalin in Rats
440
Hepatoprotection of sesquiterpenoids: A quantitative structure–activity relationship (QSAR) approach
441
Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats
442
Hepatoprotective Activity of “Orthosiphon stamineus” on Liver Damage Caused by Paracetamol in Rats
443
Hepatoprotective activity of aerial parts of Otostegia persica against carbon tetrachloride-induced liver damage in rats
444
Hepatoprotective activity of Amaranthus spinosus in experimental animals
445
Hepatoprotective activity of Andrographis Paniculata and Swertia Chirayita
446
Hepatoprotective Activity of Camellia Sinensis and Its Possible Mechanism of Action
447
Hepatoprotective Activity of Capparis spinosa Root Bark Against CCl4 Induced Hepatic Damage in Mice
448
Hepatoprotective Activity of Caspian Saffron (Crocus caspius Fisch and Mey) Flowers against CCl4 Induced Acute Liver Injury in Mice
449
Hepatoprotective Activity of Cichorium intybus L. Leaves Extract Against Carbon Tetrachloride Induced Toxicity
450
Hepatoprotective activity of colocasia antiquorum against experimentally induced liver injury in rats
451
Hepatoprotective Activity of Cucumis trigonus Roxb. Fruit against CCl4 Inducesd Hepatic Damage in Rats
452
HEPATOPROTECTIVE ACTIVITY OF Iphiona grantioides AND Pluchea arguta FOR ACETAMINOPHEN INDUCED TOXICITY IN RABBITS
453
Hepatoprotective activity of Mammea africana ethanol stem bark extract
454
Hepatoprotective Activity of Momordica diocia Roxb Fruits in CCl4-Induced Hepatotoxicity in Rats
455
Hepatoprotective activity of phloretin and hydroxychalcones against Acetaminophen Induced hepatotoxicity in mice
456
HEPATOPROTECTIVE ACTIVITY OF PHYLLANTHUS RETICULATUS
457
Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: A randomized controlled trial
458
Hepatoprotective activity of royal jelly on mercuric chloride–induced damage model in rats
459
Hepatoprotective activity of Schouwia thebica webb
460
Hepatoprotective activity of the ethanol extract of Curcuma heyneana rhizome on isoniazid and rifampin-induced liver injury rats
461
Hepatoprotective Activity of the Ethanolic Extract of Ficus carica Linn. Leaves in Carbon Tetrachloride-Induced Hepatotoxicity in Rats
462
Hepatoprotective activity of the extract of Homalium letestui stem against paracetamol-induced liver injury
463
Hepatoprotective activity of the total flavonoids from Rosa laevigata Michx fruit in mice treated by paracetamol
464
Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides Original Research Article
465
Hepatoprotective and antifibrotic effects of trans-chalcone against bile duct ligation-induced liver fibrosis in rats
466
Hepatoprotective and antiobesity effects of mirabegron, a novel β3-adrenoceptor agonist, on carbon tetrachloride-induced hepatotoxicity in obese rats
467
Hepatoprotective and Antioxidant Activities of Combination of Cinnamomum zeylanicum and Zingiber officinale in CCl4intoxicated Rats
468
Hepatoprotective and antioxidant activity of ethanolic extracts of edible lotus (Nelumbo nucifera Gaertn.) leaves
469
Hepatoprotective and Antioxidant Activity of Euphorbia tirucalli
470
Hepatoprotective and antioxidant effects of Azolla microphylla based gold nanoparticles against acetaminophen induced toxicity in a fresh water common carp fish (Cyprinus carpio L.)
471
Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO2 on CCl4-induced liver damage
472
Hepatoprotective and antioxidant effects of Commiphora berryi (Arn) Engl bark extract against CCl4-induced oxidative damage in rats
473
Hepatoprotective and Antioxidant Effects of Eupatorium ayapana against Carbon Tetrachloride Induced Hepatotoxicity in Rats
474
Hepatoprotective and antioxidant effects of lycopene in acute cholestasis
475
Hepatoprotective and Anti-oxidant effects of Nepeta Ispahanica Boiss extract on CCL4 induced liver Injury
476
Hepatoprotective and antioxidant effects of porcine plasma protein hydrolysates on carbon tetrachloride-induced liver damage in rats
477
Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice
478
Hepatoprotective and antioxidant polyphenols from a standardized methanolic extract of the leaves of Liquidambar styraciflua L.
479
Hepatoprotective and antioxidative effects of total phenolics from Laggera pterodonta on chemical-induced injury in primary cultured neonatal rat hepatocytes
480
Hepatoprotective and Hypolipidemic Effects of Carthamus tinctorius oil in Alloxan-induced Type 1 Diabetic Rats
481
Hepatoprotective and Hypolipidemic Effects of Satureja Khuzestanica Essential Oil in Alloxan-induced Type 1 Diabetic Rats
482
Hepatoprotective and hypolipidemic effects of water-soluble polysaccharidic extract of Pleurotus eryngii
483
Hepatoprotective and nitric oxide production inhibitory activities of coumarin and polyacetylene constituents from the roots of Angelica furcijuga
484
Hepatoprotective constituents from Zedoariae Rhizoma: absolute stereostructures of three new carabrane-type sesquiterpenes, curcumenolactones A, B, and C Original Research Article
485
Hepatoprotective effect and antioxidant role of sun, sulphited-dried apricot (Prunus armeniaca L.) and its kernel against ethanol-induced oxidative stress in rats
486
Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis
487
Hepatoprotective Effect of 17β-Estradiol as Antioxidant Modulators Against Stress Damage
488
Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats
489
Hepatoprotective effect of Acantholimon bracteatum (Girard) Boiss. on formaldehyde-induced liver injury in adult male mice
490
Hepatoprotective Effect of Adenema hyssopifolium G. Don (Gentianaceae) in Carbon Tetrachloride-Induced Hepatotoxicity in Rats
491
Hepatoprotective Effect of Allium hooshidaryae Hydroalcoholic Extract on Acetaminophen-Induced Hepatotoxicity in Male Rats
492
Hepatoprotective Effect of Alpha Lipoic Acid Against Bromobenzene-Induced Liver Damage in Rats
493
Hepatoprotective Effect of an Indian Salt Marsh Herb Suaeda Monoica Forsk. Ex. Gmel Against Concanavalin-A Induced Toxicity in Rats
494
Hepatoprotective Effect of Aqueous Extract of Persian Gulf Brown Algae Sargassum swartzii Against Acetaminophen-Induced Hepatotoxicity in Mice
495
HEPATOPROTECTIVE EFFECT OF CARNOSINE ON LIVER BIOCHEMICAL PARAMETERS IN CHRONIC ETHANOL INTOXICATED RAT
496
Hepatoprotective effect of chitooligosaccharides against tert-butylhydroperoxide-induced damage in Chang liver cells
497
Hepatoprotective Effect of Coenzyme Q10 in Rats with Diclofenac Toxicity
498
Hepatoprotective Effect of Cornus mas Fruits Extract Against Carbon Tetrachloride-Induced Hepatic Damage in Male Albino Rats
499
Hepatoprotective effect of Crocus sativus (saffron) petals extract against acetaminophen toxicity in male Wistar rats
500
Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice
501
Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice
502
Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice
503
Hepatoprotective Effect of Ethanolic Extract of Lavandula officinalis L. in Alloxan-Induced Diabetic Rats
504
hepatoprotective effect of ethanolic extract of lavandula officinalis l.in alloxan-induced diabetic rats
505
Hepatoprotective Effect of Ficus carica Leaf Extract on Mice Intoxicated with Carbon Tetrachloride
506
HEPATOPROTECTIVE EFFECT OF GARLIC (ALLIUM SATIVUM) AND MILK THISTLE (SILYMARIN) IN ISONIAZID INDUCED HEPATOTOXICITY IN RATS
507
Hepatoprotective Effect of Glycyrrhiza Glabra in Carbon Tetrachloride-Induced Model of Acute Liver Injury
508
Hepatoprotective effect of herbal drug on CCl4 induced liver damage
509
Hepatoprotective effect of kaempferol glycosides isolated from Cedrela odorata L. leaves in albino mice: involvement of Raf/MAPK pathway
510
Hepatoprotective Effect of Lactobacillus Plantarum Against Salmonella Typhimurium in Mice
511
Hepatoprotective Effect of Matricaria chamomilla Hot Aqueous Extract Against Methomyl 90%- Induced Hepatotoxicity In Mice
512
Hepatoprotective Effect of Microemulsion-Based System of Prunus Cerasus Kernel Extract on CCL4-induced Liver Damage in Mice
513
HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE
514
HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE
515
Hepatoprotective effect of mulberry water extracts on ethanol-induced liver injury via anti-inflammation and inhibition of lipogenesis in C57BL/6J mice
516
Hepatoprotective Effect of Otostegia persica Boiss. Shoot Extract on Carbon Tetrachloride-Induced Acute Liver Damage in Rats
517
Hepatoprotective effect of polyphenols rich methanolic extract of Amorphophallus commutatus var. wayanadensis against CCl4 induced hepatic injury in swiss albino mice
518
Hepatoprotective Effect of Pomegranate (Punica Granatum) Fruit Juice and Seed Extracts against CCL4-Induced Toxicity
519
Hepatoprotective effect of Rosa canina fruit extract against carbon tetrachloride induced hepatotoxicity in rat
520
Hepatoprotective effect of Rosmarinus officinalis and rosmarinic acid on acetaminophen-induced liver damage
521
Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect
522
Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect
523
Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism
524
Hepatoprotective Effect of Silymarin and Propolis in Chemically Induced Chronic Liver Injury in Rats
525
Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats
526
Hepatoprotective effect of the root extract of green tea against malathion-induced oxidative stress in rats
527
hepatoprotective effect of vitamin b12 in acetaminophen induce hepatotoxicity in male rats
528
Hepatoprotective effect of vitamins C and E against gasoline vapor-induced liver injury in male rats
529
Hepatoprotective Effect of Zizyphus vulgaris on Carbon Tetrachloride (CCl4) Induced Liver Damage in Rats as Animal Model
530
Hepatoprotective effect of β-myrcene pretreatment against acetaminophen-induced liver injury
531
Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin
532
Hepatoprotective effects of almond oil against carbon tetrachloride induced liver injury in rats
533
Hepatoprotective Effects of Arbutin against Liver Damage Induced by Carbon Tetrachloride in Rats
534
Hepatoprotective effects of Artemia salina L. extract against carbon tetrachloride-induced toxicity
535
Hepatoprotective Effects of Avicennia marina (Forssk.) Vierh.
536
HEPATOPROTECTIVE EFFECTS OF BERBERIS LYCIUM, GALIUM APARINE AND PISTACIA INTEGERRIMA IN CARBON TETRACHLORIDE (CCL4)-TREATED RATS
537
Hepatoprotective effects of betaine on liver damages followed by myocardial infarction
538
Hepatoprotective Effects of Biochanin A Against Acetaminophen-Induced Liver Toxicity in Mice
539
Hepatoprotective Effects of Black Pomegranate (Punica granatum L.) Peel Extract on Tert-Butyl Hydroperoxide Induced Oxidative Stress in Rats
540
Hepatoprotective effects of chestnut (Castanea crenata) inner shell extract against chronic ethanol-induced oxidative stress in C57BL/6 mice
541
Hepatoprotective Effects of Chitosan and Chitosan Nanoparticles against Biochemical, Genetic, and Histological Disorders Induced by the Toxicity of Emamectin Benzoate
542
Hepatoprotective Effects of Coenzyme Q10 against Amoxiclav-induced Hepatotoxicity in the Rat Model
543
Hepatoprotective Effects of Combination Hydroalcoholic Extracts of Nigella Sativa and Curcuma Longa on Adriamycin- Induced Oxidative Stress in Rat
544
Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice
545
Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury
546
Hepatoprotective Effects of Ethanol Extract of Caesalpiniabonduc against Carbon Tetrachloride Induced Hepatotoxicity in Albino Rats
547
Hepatoprotective effects of fermented Curcuma longa L. on carbon tetrachloride-induced oxidative stress in rats
548
Hepatoprotective effects of fermented field water-dropwort (Oenanthe javanica) extract and its major constituents
549
Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats
550
Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice
551
Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on Nuclear Factor-kappa B pathway in thioacetamide-induced fibrosis in rats
552
Hepatoprotective Effects of Hertia cheirifolia Butanolic Extract and Selenium against CCl4 -induced Toxicity in Rats
553
Hepatoprotective effects of hydroethanolic extracts of Crocus sativus tepals, stigmas and leaves on carbon tetrachloride induced acute liver injury in rats
554
Hepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in mice
555
Hepatoprotective effects of Lycium chinense Miller fruit and its constituent betaine in CCl4-induced hepatic damage in rats
556
Hepatoprotective effects of Malva sylvestris L. against paracetamol-induced hepatotoxicity
557
Hepatoprotective Effects of Opuntia dillenii Haw Fruit in a Mice Model of Lung Cancer
558
Hepatoprotective Effects of Pentoxifylline against Acrolein-Induced Mitochondrial Dysfunction in Rat Liver
559
Hepatoprotective effects of Platycodon grandiflorum on acetaminophen-induced liver damage in mice
560
Hepatoprotective Effects of Propolis Extract: A Biochemical and Histopathological Approach
561
Hepatoprotective effects of purified oleuropein from olive leaf extract against ethanol-induced damages in the rat
562
Hepatoprotective Effects of Silymarin on Liver Injury via Irisin Upregulation and Oxidative Stress Reduction in Rats with Type 2 Diabetes
563
Hepatoprotective Effects of Taraxacum officinale Root Extract on Permethrin-induced Liver Toxicity in Adult Mice
564
Hepatoprotective effects of total saponins isolated from Taraphochlamys affinis against carbon tetrachloride induced liver injury in rats
565
Hepatoprotective efficacy of Grewia asiatica fruit against oxidative stress in swiss albino mice
566
Hepatoprotective Evaluation of Butea monosperma against Liver damage by Paracetamol in Rabbits
567
Hepatoprotective glycosides from Leonurus japonicus Houtt. Original Research Article
568
Hepatoprotective Herbs, Avicenna Viewpoint
569
Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins
570
Hepatoprotective potential and antioxidant activity of Allium tripedale in acetaminophen-induced oxidative damage
571
Hepatoprotective potential of polyphenol rich extract of Murraya koenigii L.: An in vivo study
572
Hepatoprotective Potential of Prosopis farcta Beans Extracts against Acetaminophen-induced Hepatotoxicity in Wister Rats
573
Hepatoprotective potential of Saraca ashoka (Roxb.) De Wilde bark by carbon tetrachloride induced liver damage in rats
574
Hepatoprotective potentials of Phyllanthus amarus against ethanol-induced oxidative stress in rats
575
Hepatoprotective principles from the flowers of Tilia argentea (Linden): structure requirements of tiliroside and mechanisms of action Original Research Article
576
Hepatoprotective Properties of Cuminum cyminum Seeds Powder as Post-Treatment for Acetaminophen-Induced Injury
577
Hepatoprotective properties of p-coumaric acid in a rat model of ischemiareperfusion
578
Hepatoprotective properties of sesamin against CCl4 induced oxidative stress-mediated apoptosis in mice via JNK pathway
579
Hepatoprotective properties of the glycolipoprotein extract from Eisenia foetida
580
Hepatoprotective pyrrole derivatives of Lycium chinense fruits
581
Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats
582
Hepatoprotective Role of Milk Thistle (Silybum marianum) in Meat Type Chicken Fed Aflatoxin B1 Contaminated Feed
583
HEPATOPROTECTIVE STUDIES ON HALOXYLON SALICORNICUM: A PLANT FROM CHOLISTAN DESERT
584
Hepatoprotective, anti-inflammatory and antioxidant activities of Flacourtia montana J. Grah leaf extract in male Wistar rats
585
Hepatoprotective, superoxide scavenging, and antioxidative activities of aromatic constituents from the bark of Betula platyphylla var. japonica
586
Hepatoprotetive, Cardioprotective and Nephroprotective Actions of Essential Oil Extract of Artemisia sieberi in Alloxan Induced Diabetic Rats
587
Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study
588
Hepatopulmonary syndrome associated with Budd-Chiari syndrome
589
Hepatopulmonary syndrome associated with cardiorespiratory disease
590
Hepatopulmonary syndrome in candidates for liver transplantation
591
Hepatopulmonary syndrome in patients with Schistosoma mansoni periportal fibrosis
592
Hepatopulmonary syndrome in transplant centres at different altitudes
593
Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data
594
Hepatopulmonary syndrome: Angiography and therapeutic embolization
595
Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS)
596
Hepatorenal and genotoxic effects of genetically modified quail meat in a 90-day dietary toxicity study in mice
597
Hepatorenal and Testicular Functions Concomitant with Induced Hypo and Hyperprolactinemia in Male Rats
598
Hepato-Renal Dysfunctions Induced by Gold Nanoparticles and Preservative Efficacy of Black Seed Oil
599
Hepatorenal effect of prolonged low-flow sevoflurane anesthesia on patients with renal impairment
600
Hepatorenal Protective Effects of Sesame Seeds Oil, Flaxseed Oil and their Mixture against Methotrexate Toxicity in Rats
601
Hepatorenal syndrome
602
Hepatorenal syndrome: Response to terlipressin and albumin and its determinants
603
Hepatorenal-toxicities Accompanying Exposure to Indoor Air Pollutants in Chemical Storekeepers at an International Market
604
Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors
605
Hepatosplenic Candidiasis Detected by ^18F-FDG-PET/CT
606
Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India
607
Hepato-Splenic gamma sigma T-Cell Lymphoma: A Rare Entity Mimicking the Hemophagocytic Syndrome
608
HEPATOSPLENIC MORBIDITY IN SCHISTOSOMIASIS JAPONICA: EVALUATION WITH DOPPLER SONOGRAPHY
609
Hepatosplenic Mucor Balls
610
Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum
611
Hepatosplenic γδ T cell lymphoma: a diagnostic pitfall
612
Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase −1 exon 8 splice junction mutation
613
Hepatotoxic and Nephrotoxic Effects of Kerosene on Female Wistar Rats: a Comparison of Two Routes of Exposure
614
Hepatotoxic Effect of Hydrogen Cyanamide (Dormex®) in Albino Rats and the Ameliorative Effect of Melatonin
615
HEPATOTOXIC EFFECT OF NICKEL SULPHATE ON MICE
616
Hepatotoxic effects of mycotoxin combinations in mice
617
Hepatotoxic microcystin diversity in cyanobacterial blooms collected in portuguese freshwaters
618
Hepatotoxicity After Exposure to Tebuconazole: A Case Report and Brief Review
619
Hepatotoxicity Among Poisoned Patients: A Cross-sectional Study
620
Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice
621
Hepatotoxicity and genotoxicity of patulin in mice, and its modulation by green tea polyphenols administration
622
Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice
623
HEPATOTOXICITY ASSOCIATED WITH HYPOGLYCEMIC EFFECTS OF TEUCRIUM POLIUM IN DIABETIC RATS
624
Hepatotoxicity associated with the ingestion of Papaver Rhoease
625
Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)
626
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): A growing concern
627
Hepatotoxicity Due To Mushroom Poisoning: A Case Report
628
Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting
629
Hepatotoxicity in Both Occupationally and Environmentally-Exposed Inhabitants of a Lead-Zinc Mining Community
630
Hepatotoxicity in drug development: detection, significance and solutions
631
Hepatotoxicity in sheep and goats caused by experimental feeding with foxtail millet (Setariaitalica)
632
Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study
633
Hepatotoxicity induced by iron overload and alcohol : Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation
634
Hepatotoxicity of androstenedione in pregnant rats
635
Hepatotoxicity of Antiretroviral Drugs in HIV Seropositive Nigerian Patients
636
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
637
HEPATOTOXICITY OF CARBON TETRACHLORIDE: PROTECTIVE EFFECT OF GONGRONEMA LATIFOLIUM
638
Hepatotoxicity of Dorema Aucheri (Bilhar) in Albino Mice
639
Hepatotoxicity of Halogenated Inhalational Anesthetics
640
Hepatotoxicity of herbal remedies
641
Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice
642
Hepatotoxicity of monobromobenzene and hexabromobenzene: effects of repeated dosage in rats
643
Hepatotoxicity of non-narcotic analgesics
644
Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials
645
Hepatotoxicity of Polyethylene Glycol and Possible Protection Using Moringa Oleifera Leaves Extract (MOLE)
646
Hepatotoxicity of polyunsaturated fatty acids in alcohol abuser
647
Hepatotoxicity of tubers of Indian Kudzu (Pueraria tuberosa) in rats
648
Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly- -lysine : Synthesis of the carrier and pharmacological properties of the conjugate
649
Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines
650
Hepato-vagal pathway associated with nicotineʹs anorectic effect in the rat
651
Hepatozoon species infections in Nigeria
652
He–Pb double dating of detrital zircons from the Ganges and Indus Rivers: Implication for quantifying sediment recycling and provenance studies
653
Hepcidin and anaemia
654
Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major
655
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload
656
Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients
657
Hepcidin Gene Cloning and Expression Pattern in Turbot (Scophthalmus maximus) after Vibrio. anguillarum Infection
658
Hepcidin gene expression induced in the developmental stages of fish upon exposure to Benzo[a]pyrene (BaP)
659
Hepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytes
660
Hepcidin in hemodialysis patients and its association with anemia and serum iron indices
661
Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction?
662
Hepcidin Induces M1 Macrophage Polarization in Monocytes or THP-1 Derived Macrophages
663
Hepcidin is a friend rather than a foe in COVID19-induced complications
664
Hepcidin mimetics from microorganisms? A possible explanation for the effect of Helicobacter pylori on iron homeostasis
665
Hepcidin, A New Iron Regulatory Peptide
666
Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery
667
Hepcidin: A multitask molecule in fish
668
Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages
669
HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium
670
HEPHESTUS: An expert system in PROLOG for the interpretation of the pyrolysis-mass spectra of polyesters, polyethers and polyureas using the certainty factor model
671
HEPI: A new tool for human error probability calculation for offshore operation
672
HepML, an XML-based format for describing simulated data in high energy physics Original Research Article
673
HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells
674
HEP-NET OPINION ABOUT THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS C IN PAKISTAN IN THE ERA OF AVAILABLE DIRECT ACTING ANTIVIRALS
675
Hepsin promotes prostate cancer progression and metastasis
676
Hept-1-yne partial hydrogenation reaction over supported Pd and W catalysts Original Research Article
677
Heptacoordinate dithiophosphate Mo(II) and W(II) complexes: molecular structures of mono and binuclear phosphine complexes
678
Heptacoordinate dithiophosphate W(II) and Mo(II) complexes of diphosphines and iodide
679
Heptacoordinate tricarbonyl Mo(II) complexes as highly selective oxidation homogeneous and heterogeneous catalysts
680
Heptacoordinated diphenyllead; hexa- and pentacoordinated triphenyllead and tin compounds derived from 5H-benzimidazo[1,2-c]quinazoline-6-thione
681
Heptacyclo[6.6.0.02,6.03,13.04,11.05,9.010,14]tetradecane: a new type of spacer for mediating electron transfer processes
682
Heptadecafluorooctanesulfonic acid (C8F17SO3H) catalyzed intramolecular hydroamination of olefinic sulfonamides in fluorous biphase system (FBS)
683
Heptadecanols from the leaves of Persea americana var. americana
684
Heptadentate Schiff-base based PVC membrane sensor for Fe(III) ion determination in water samples
685
Heptahelical receptor signaling in heart failure
686
Heptakis(2,3-di-O-carboxymethyl)-(beta)-cyclodextrin as a pH-sensitive Host
687
Heptakis(6-deoxy-6-guanidino)-β-cyclodextrin: an artificial model for mitochondrial ADP/ATP carrier
688
Heptakis[6-S-(2,3-dihydroxypropyl)-6-thio] cyclomaltoheptaose and its sulfone: water-soluble β-cyclodextrin derivatives having modified polarity
689
Heptakis-6-(5-methylene-thioureido-5′-methyl-2,2′-bipyridyl)-β-cyclodextrin: synthesis and metal complexation study
690
Heptakis-6-(5-methylene-ureido-5′-methyl-2,2′-bithiazolyl)-cyclomaltoheptaose as a new fluorescent polydentate ligand
691
Heptane isomerization over molybdenum oxides obtained by H2 reduction of HxMoO3 with different hydrogen contents Original Research Article
692
Heptane Reforming over Pt–Re/Al2O3: Reaction Network, Kinetics, and Apparent Selective Catalyst Deactivation
693
Heptanuclear and Decanuclear Manganese Complexes with the Anion of 2-Hydroxymethylpyridine
694
Heptanuclear cobalt(II) dicubane compounds with single-molecule magnet behavior
695
Heptaphyrins: Expanded porphyrins with seven heterocyclic rings
696
Heptyl oleate synthesis as useful tool to discriminate between lipases, proteases and other hydrolases in crude preparations
697
Her 2 in 1
698
Her 2 Overexpression in Breast Carcinoma; Its Significance and Association with Age and Tumor Grade
699
Her Majesty’s coroners and Home Office forensic pathologists perception of the nurses’ role in the coroner’s enquiry
700
Her records
701
Her story of cognitive science
702
HER2 aberrations in cancer: Implications for therapy
703
HER2 and proliferation of wound-induced breast carcinoma
704
HER2 and proliferation of wound-induced breast carcinoma
705
HER2 and proliferation of wound-induced breast carcinoma
706
HER2 and surgery: more questions to answer
707
HER2 discordance between primary and metastatic breast cancer: Assessing the clinical impact
708
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization
709
HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma
710
HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer—A study of two hundred cases
711
HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer
712
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors
713
HER2 Overexpression in Borderline and Malignant Ovarian Tumors: A Cross-sectional Study in an Iranian Population and Literature Review
714
HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription
715
HER2 Protein Overexpression in Infiltrating Ductal Carcinoma of the Breast Associated with Lymph Node Involvement
716
HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana
717
HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
718
HER2 status and UPA/PAI-1 provide complementary information on patient outcome in node-negative breast cancer
719
HER2 status in advanced breast cancer: which option for aromatase inhibitors?
720
HER2 Testing in Invasive Breast Cancer: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization Assays
721
HER2 testing: Current status and future directions
722
HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?
723
HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia
724
HER2/neu expression in bladder cancer: relationship to cell cycle kinetics
725
Her-2/Neu Expression in Bladder Urothelial Carcinoma
726
HER-2/neu Expression in Resectable Gastric Cancer and its Relationship with Histopathologic Subtype, Grade, and Stage
727
Her2/neu Expression in Wilmsʹʹ Tumor and Correlation With Histopathologic Findings
728
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
729
HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
730
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
731
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
732
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
733
Her-2/Neu, Estrogen and Progesterone Receptor Expression In WHO Grade I Meningiomas
734
HER2/neu: A Prognostic Marker for Ovarian Carcinoma
735
HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization
736
HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
737
HER2-Positive Breast Cancer: Tumor-to-Liver SUV Ratio is the Best Parameter for Detection in F-18 FDG-PET/CT
738
Her2-specific Multivalent Adapters Confer Designed Tropism to Adenovirus for Gene Targeting
739
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
740
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
741
HER-3 Knocking Down Induces G2/M Arrest in Gastric Cancer Cells
742
HER4 rs1595065 3ʹUTR Variant is a Possible Risk Factor for HER2 Positivity Among Breast Cancer Patients
743
HERA and the asymptotic behaviour of F2p
744
HERA anomaly and hard charm in the nucleon
745
HERA collider physics
746
HERA data and DGLAP evolution: Theory and phenomenology
747
HERA events, tevatron jets, and uncertainties on quarks at large x
748
HERA prospects on compositeness and new vector bosons
749
HERA results on electroweak interactions at high momentum transfers
750
HERA results on the structure of the proton
751
HERA today, gone tomorrow?
752
HERA-3 Original Research Article
753
HERA-B data acquisition system
754
HERA-B data acquisition system
755
HERA-B framework for online calibration and alignment
756
HERA-B framework for online calibration and alignment
757
HERA-B higher-level triggers: architecture and software
758
HERA-B higher-level triggers: architecture and software
759
HERA-B RICH
760
HERA-B RICH
761
HERA-B RICH light collection system
762
HERA-B RICH light collection system
763
HERA-B RICH: Performance and physics impact
764
HERA-B RICH: Performance and physics impact
765
HERA-B status
766
HERA-B status
767
HERA-B triggering
768
HERA-B, an experiment to study CP violation at the HERA proton ring using an internal target
769
HERA-B: overview and 1996 engineering run
770
HERA-B: overview and 1996 engineering run
771
HERA-B: overview and engineering runs
772
HERA-B: overview and engineering runs
773
HERA-B: physics potential and prospects
774
HERA-B: physics potential and prospects
775
HERA-B: status and commissioning results
776
HERA-B: status and commissioning results
777
HERA-B: trigger system
778
HERA-B: trigger system
779
HERACLES-II setup at TRIUMF
780
HERACLES-II setup at TRIUMF
781
HERA-data in the light of small x evolution with state of the art NLO input
782
Heraeus acquires BASFʹs business in ceramic & glassware colorants
783
Herakles’in On İki İşi Betimli Mozaik Hakkında Tespitler
784
Heralded two-photon entanglement from probabilistic quantum logic operations on multiple parametric down-conversion sources
785
Herb and vitamin upplementation ue among a general ophthalmology practice population
786
Herb digoxin interactions
787
Herb gallwasp Neaylax salviae (Giraud, 1859) (Hymenoptera, Aylacini) – new record from Turkey
788
Herb layer extinction debt in highly fragmented temperate forests – Completely paid after 160 years?
789
Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats
790
Herb Target Prediction Using Machine Learning Methods in a Heterogeneous Network
791
Herbaceous biomass retrieval in habitats of complex composition: a model merging SAR images with unmixed Tlandsat TM data
792
Herbaceous energy crops: A general survey and a microeconomic analysis
793
Herbaceous layer response to 17 years of controlled deer hunting in forested natural areas
794
Herbaceous plant biomass harvest and delivery cost with harvest segmented by month and number of harvest machines endogenously determined
795
Herbaceous vegetation response to grazing exclusion in patches and inter-patches in semi-arid pasture and woody encroachment
796
Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway
797
Herbage and Animal Responses to Management Intensity of Continuously Stocked Bahiagrass Pastures
798
Herbage and Seed Production of Two Species of Lathyrus L. under Rainfed Condition of Borujerd, Iran
799
Herbage biomass production and nutritive value of mulberry (Morus alba) and Calliandra calothyrsus harvested at different cutting frequencies
800
Herbage intake and milk yield of dairy cows grazing perennial ryegrass swards or white clover/perennial ryegrass swards at low- and medium-herbage allowances
801
HERBAGE MINERAL NUTRITION INDEXED AS TOOLS FOR RAPID MINERAL STATUS DIAGNOSIS IN TROPICAL PASTURES
802
Herbage production and chemical characteristics for bioenergy production by plant functional groups from semi-natural grasslands
803
Herbage yield in Signalgrass pastures as affected by grazing management
804
Herbage yield of Persian clover (Trifolium resupinatum L.) as affected by row distance and herbicide application
805
Herbal agents and over-the-counter medications in pregnancy
806
Herbal and Conventional Toothpastes Roles in Gingivitis Control in Orthodontic Patients
807
Herbal and Dietary Supplement–Drug Interactions in Patients Taking Digoxin
808
Herbal and nutritional supplement use among college students in Qatar
809
Herbal Appetizer for Children with Failure to Thrive (FTT) in View of Traditional Persian Medicine: A Review
810
HERBAL APPROACHES FOR EPILEPSY: A REVIEW
811
Herbal Cosmeceuticals for Photoprotection from Ultraviolet B Radiation: A Review
812
Herbal cosmeceuticals: New opportunities in cosmetology
813
Herbal Diet and the Impact of Nutrition on Lipogenic Activity, a System Biology Study
814
Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products
815
Herbal Drugs with Promising Anti-Leishmanial Activity: New Hope for Leishmaniasis Treatment
816
Herbal Extract Decolourization Device Using Activated Carbon
817
Herbal extracts and essential oils microencapsulation studies for different applications
818
Herbal Fertility Remedies Leading to Massive Pulmonary Embolism: A Case Report
819
Herbal formula CGX ameliorates LPS/d-galactosamine-induced hepatitis
820
Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports
821
Herbal infusions bioelectrochemical polyphenolic index: Green tea – The gallic acid interference
822
Herbal infusions; their phenolic profile, antioxidant and anti-inflammatory effects in HT29 and PC3 cells
823
HERBAL INTAKE: UNDIAGNOSED HYPOTHYROIDISM LEADING TO POSTOPERATIVE REFRACTORY CIRCULATORY COLLAPSE - A Case Report -
824
Herbal Medications to Manage Insomnia: An Overview of Clinical Trials using Herbal Treatment for Insomnia
825
Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential
826
Herbal Medicinal Products, Medpharm, Stuttgart, Germany, F. Gaedcke, B. Steinhoff, H. Blasius (Eds.). CRC Press, Boca Raton, USA (2003)
827
Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry
828
Herbal medicine and liver disease, for any conclusion we need to do more studies
829
Herbal Medicine and Sexual Behavior in Diabetic Patients
830
Herbal Medicine and Vaginal Candidiasis in Iran: A Review
831
Herbal Medicine and Vaginal Candidiasis in Iran: A Review
832
Herbal Medicine as Inducers of Apoptosis in Cancer Treatment
833
Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview
834
Herbal medicine heads for the mainstream
835
Herbal Medicine in the Treatment of Premenstrual Syndromes
836
Herbal Medicine in Treatment of Recurrent Aphthous Stomatitis: A Literature Review
837
Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet
838
Herbal Medicine Isolation, Phaleria macrocarpa for primary glioblastoma multiforme cells
839
Herbal medicine Sho-saiko-to (TJ-9) prevent liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient -amino acid-defined diet
840
Herbal medicine under scrutiny
841
Herbal Medicine, Second Edition.: Rudolf Fritz Wiess, MD and Volker Fintelmann, MD. ISBN 0-86577-970-8, Thieme, NY, 438 pp.
842
Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects
843
Herbal Medicines and Epilepsy: To the Editor
844
Herbal Medicines and Other Traditional Remedies in Iran – A Tragedy Unfolds
845
Herbal Medicines and Reactivation of Chronic Hepatitis B Virus Infection
846
Herbal Medicines for Immunosuppression
847
Herbal Medicines in Diabetes
848
Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders
849
Herbal Medicines Used in Kidney Diseases in Europe
850
Herbal Medicines Used in Treatment of Nonalcoholic Fatty Liver Disease: A Mini-Review
851
Herbal medicines: a new hope for autism therapy
852
Herbal Medicines: from Traditional Medicine to Modern Experimental Approaches
853
Herbal medicines—primum non nocere
854
Herbal Nanoemulsion in Topical Drug Delivery and Skin Disorders: Green Approach
855
Herbal nano-ointment containing encapsulated polysaccharide in repairing of superficial ulcers
856
Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review
857
Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review
858
Herbal Products in Cesarean Wound Healing
859
Herbal Products in the Care and Prevention of Breast Fissure in Lactating Women: A Systematic Review
860
Herbal Products Review Provides Inaccurate Information on Dietary Supplement Regulations
861
Herbal Products Review: What Do We Really Know?
862
Herbal Products Use During Pregnancy in North of Iran
863
Herbal remedies and medicine; introducing some Iranian plants
864
Herbal Remedies CD-ROM, T. Brendler, J. Gruenwald, C. Jaenicke (Eds.). Medpharm GmbH Scientific Publishers, Stuttgart Germany (2003)
865
Herbal Remedies Connected to Malaria like Fever in Iranian Ancient Medicinal Books- Brief Review Article.
866
Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis
867
Herbal Remedies for Acne Vulgaris from the Viewpoint of Persian Medicine
868
Herbal Remedies for Cancer based on Persian Medicine
869
Herbal Remedies for Functional Dyspepsia and Traditional Iranian Medicine Perspective
870
Herbal remedies for oligomenorrhea in Traditional Persian Medicine
871
Herbal Remedies for Pediatric Earache in Traditional Iranian Medicine
872
Herbal remedies—how safe are they? A case report of polymorphic ventricular tachycardia/ventricular fibrillation induced by herbal medication used for obesity
873
Herbal Research: Gaps Affecting the Quality and Validity of Research Findings
874
HERBAL RMIDIES USED FOR GASTROINTESTINAL DISORDERS IN KAGHAN VALLEY, NWFP, PAKISTAN
875
Herbal self-medication use in patients with diabetes mellitus type 2
876
Herbal Supplement Use and Herb–drug Interactions among Patients with Kidney Disease
877
Herbal supplementation diets on hematology and innate immunity in goldfish against Aeromonas hydrophila
878
Herbal Therapy and Treatment of Worm Infections, Emphasizing Taenia solium
879
Herbal Therapy for Burn Wound Infections
880
Herbal therapy in Covid-19: A systematic review of medicinal plants effective against Covid-19
881
Herbal therapy in opioid withdrawal syndrome: A systematic review of randomized clinical trials
882
HERBAL TREATMENT FOR CARDIOVASCULAR DISEASE THE EVIDENCE BASED THERAPY
883
Herbal Treatment of Hypertension: A Literature Review
884
Herbal Treatment of Oligomenorrhea with Sesamum indicum L.: A Randomized Controlled Trial
885
Herbal treatment options for female fertility disorders: a systematic review of clinical trials
886
Herbal Treatments for Asthma, according to Avicenna
887
Herbal Treatments to Gain Weight as the Potential Cause of Portal Vein Thrombosis and Hepatic Damage: A Case Report
888
Herbal Whitening Agents: Traditional Remedies for Reducing Tooth Discoloration
889
Herbal, Animal and Mineral Remedies in Burn Wound: a review of Persian Traditional Medicine literature
890
Herbal-caffeinated chewing gum, but not bubble gum, improves aspects of memory
891
Herbals in cardiovascular practice: Are physicians neglecting anything?
892
Herbarium images launched
893
Herbarium specimens demonstrate earlier flowering times in response to warming in Boston
894
Herb–drug interaction of Fucus vesiculosus extract and amiodarone in rats: A potential risk for reduced bioavailability of amiodarone in clinical practice
895
Herb-drug interactions
896
Herb-drug interactions
897
Herb–drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats
898
Herbert Blankenhorn in the Third Reich
899
Herbert Bower
900
Herbert D. Kelleher, Southwest Airlines, 2003 Bower Award for Business Leadership laureate
901
Herbert Holik (Ed.), Handbook of paper and board, Wiley-VCH, Weinheim, Germany, 2006 (xix+505, £105-00, ISBN: 3-527-30997-7)
902
Herbert Robbins and sequential analysis
903
Herbert screw fixation of capitellar fractures
904
Herbert Simon and behavioral economics
905
Herbert Simon and the concept of dispersed entrepreneurship
906
Herbert Simon. Artificial intelligence as a framework for understanding intuition
907
Herbicidal activity of allelopathic extracts of sorghum and some herbicides on wheat and accompanied weeds
908
Herbicidal activity of constituents isolated from Solanum elaeagnifolium (Solanaceae)
909
HERBICIDAL ACTIVITY OF Datura metel L. AGAINST Phalaris minor Retz
910
Herbicidal activity of eight isothiocyanates on Texas panicum (Panicum texanum), large crabgrass (Digitaria sanguinalis), and sicklepod (Sennaobtusifolia)
911
Herbicidal Activity of Mycelial and Cell Free Extracts of Fusarium oxysporum F.sp. Ciceris Against Rice Weed Cyperus Iria l
912
HERBICIDAL ACTIVITY OF SOME MEDICINAL PLANTS EXTRACTS AGAINST Parthenium hysterophorus L.
913
Herbicidal and antioxidant responses of transgenic rice overexpressing Myxococcus xanthus protoporphyrinogen oxidase
914
HERBICIDAL CONTROL OF Lantana camara
915
HERBICIDAL EFFECT OF FICUS BENGALENSIS AQUEOUS EXTRACT ON IPOMOEA PENTAPHYLLA
916
Herbicidal effects under field conditions of Ailanthus altissima bark extract, which contains ailanthone
917
Herbicidal ionic liquid with dual-function
918
Herbicidal potential of Azadirachta indica leaves extract against Achyranthes aspera and Senna occidentalis
919
Herbicidal, Insecticidal and Structure-Activity Relationship Studies on Pyranopyrazole and Oxinobispyrazole Derivatives
920
Herbicide accumulation and evolution in reservoir sediments Original Research Article
921
Herbicide and insect resistant elite transgenic rice
922
Herbicide and metabolite movement in different soils as studied by computer assisted microlysimeters
923
Herbicide and plant growth regulator analysis by capillary electrophoresis
924
Herbicide concentrations in the Mississippi River Basin—the importance of chloroacetanilide herbicide degradates
925
Herbicide contamination and dispersion pattern in lowland springs Original Research Article
926
Herbicide contamination and the potential impact to seagrass meadows in Hervey Bay, Queensland, Australia
927
HERBICIDE CONTAMINATION IN CARROT GROWN IN PUNJAB, PAKISTAN
928
Herbicide contamination of surficial groundwater in Northern Italy
929
Herbicide dissipation and dynamics modelling in three different tillage systems
930
Herbicide distribution in soils of a riparian forest and neighboring sugar cane field
931
Herbicide dose and incorporation depth in combination with 1,3- dichloropropene plus chloropicrin for Cyperus rotundus control in tomato and pepper
932
Herbicide drift can affect plant and arthropod communities
933
Herbicide effect on growth and seed production of Lolium multiflorum in Atlantic Canada
934
Herbicide effects on typha latifolia (Linneaus) germination and root and shoot development
935
Herbicide evaluation for the control of wild taro
936
Herbicide impact on Hormosira banksii gametes measured by fluorescence and germination bioassays
937
Herbicide Isoproturon-Specific Binding in the Freshwater Macrophyte Elodea densa-A Single-Cell Fluorescence Study
938
Herbicide loss in surface runoff from a pastoral hillslope in the Pukemanga catchment (New Zealand): Role of pre-event soil water content
939
Herbicide losses in runoff events from a field with a low slope: Role of a vegetative filter strip
940
Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants CoExpressing Human CYP1A1, CYP2B6, and CYP2C19
941
Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants Expressing Human CYP1A1
942
Herbicide Metabolism and Tolerance in the Transgenic Rice Plants Expressing Human CYP2C9 and CYP2C19
943
Herbicide Residues in Water Resources: A Scoping Review
944
Herbicide Resistance and Supersensitivity in Ala250 or Ala251 Mutants of the D1 Protein in Chlamydomonas reinhardtii,
945
Herbicide resistance dynamics in a spatially heterogeneous environment
946
HERBICIDE RESISTANCE IN ANNUAL RYEGRASS (Lolium rigidum Gaud.) POPULATIONS IN WHEAT FIELDS OF FIROOZABAD IRAN
947
Herbicide Retention in Soil as Affected by Sugarcane Mulch Residue
948
Herbicide risk assessment for non-target aquatic plants: sulfosulfuron - a case study
949
Herbicide safeners: uses, limitations, metabolism, and mechanisms of action
950
Herbicide Selectivity applied in post-emergence of Mulato II grass
951
Herbicide sensitivity of Echinochloa spp. accessions in Italian rice fields
952
Herbicide sorption, degradation, and leaching in three Swedish soils under long-term conventional and reduced tillage
953
Herbicide tolerance in maize is related to increased levels of glutathione and glutathione-associated enzymes
954
Herbicide toxicity of Halophila ovalis assessed by chlorophyll a fluorescence
955
Herbicide transport by surface runoff and herbicide retention in a filter strip — Rainfall and runoff simulation studies
956
Herbicide transport via surface runoff during intermittent artificial rainfall: A laboratory plot scale study
957
Herbicide/Pesticide Effects on Intestinal Epithelial Growth,
958
Herbicides affect fluorescence and electron transfer activity of spinach chloroplasts, thylakoid membranes and isolated Photosystem II
959
Herbicides and herbicide degradates in shallow groundwater and the Cedar River near a municipal well field, Cedar Rapids, Iowa
960
Herbicides and Herbicide Degradation Products in Upper Midwest Agricultural Streams during August BaseFlow Conditions
961
Herbicides and nitrogen in precipitation: progression from west to east and contribution to the Marne river (France)
962
HERBICIDES AND THEIR DOSES EFFECTS ON WILD ONION (Asphodelus tenuifolius Cav.) IN CHICKPEA
963
Herbicides and their mechanisms of action. Sheffield Biological Sciences, Volume 6. Edited by Andrew Cobb and Ralph Kirkwood. 2000.
964
Herbicides and Transformation Products in Surface Waters of the Midwestern United States
965
Herbicides for control of isoproturon-resistant Littleseed Canarygrass (Phalaris minor) in wheat
966
Herbicides for control of metsulfuron resistant toothed dock (Rumex dentatus)
967
Herbicides genotoxicity
968
Herbicides genotoxicity
969
Herbicides have negligible effects on ants and springtails in an Australian wheat field
970
Herbicides have negligible effects on ants and springtails in an Australian wheat field
971
Herbicides implicated as the cause of severe mangrove dieback in the Mackay region, NE Australia: consequences for marine plant habitats of the GBR World Heritage Area
972
HERBICIDES, THEIR APPLICATION TIMINGS AND DIFFERENT SOIL TEMPERATURE REGIMES AFFECT WEED INFESTATION IN WHEAT
973
Herbicides, weeds and endangered species: management of bitou bush (Chrysanthemoides monilifera ssp. rotundata) with glyphosate and impacts on the endangered shrub, Pimelea spicata Original Research Article
974
Herbicide-tolerant sugarcane (Saccharum officinarum L.) plants: an unconventional method of weed removal
975
Herbivore and pollinator responses to grassland management intensity along experimental changes in plant species richness
976
Herbivore diet selection in response to simulated variation in nutrient rewards and plant secondary compounds
977
Herbivore host choice and optimal bad motherhood
978
Herbivore species and density affect vegetation-structure patchiness in salt marshes
979
Herbivore-associated elicitors: FAC signaling and metabolism
980
Herbivore-associated elicitors: FAC signaling and metabolism
981
Herbivore-induced coexistence of competing plant species
982
Herbivore-Induced Defense Response in a Model Legume. Two-Spotted Spider Mites Induce Emission of (E)-(beta)Ocimene and Transcript Accumulation of (E)-(beta)-Ocimene Synthase in Lotus japonicus
983
Herbivores alter the fitness benefits of a plant–rhizobium mutualism
984
Herbivores Coprolites from Chehrabad Salt Mine of Zanjan, Iran (Sassanid Era, 224-651 AD) Reveals Eggs of Strongylidae and Anoplocephalidae Helminths
985
Herbivores enable plant survival under nutrient limited conditions in a model grazing system
986
Herbivores enable plant survival under nutrient limited conditions in a model grazing system
987
Herbivores, the Functional Diversity of Plants Species, and the Cycling of Nutrients in Ecosystems
988
Herbivorous and microbial grazing pathways of metazooplankton in the Senegal River Estuary (West Africa)
989
Herbivory alters competitive interactions between two invasive aquatic plants
990
Herbivory alters the expression of a mixed-mating system
991
Herbivory and seedling performance in a fragmented temperate forest of Chile
992
Herbivory at marginal populations: Consequences for maternal fitness and vegetative differentiation
993
Herbivory by the pine weevil (Hylobius abietis L.) and short-snouted weevils (Strophosoma melanogrammum Forst. and Otiorhynchus scaber L.) during the conversion of a wind-thrown Norway spruce forest into a mixedspecies plantation
994
Herbivory by the weevil, Strophosoma melanogrammum, causes severalfold increase in emission of monoterpenes from young Norway spruce (Picea abies)
995
HERBIVORY COULD UNLOCK MUTATIONS SEQUESTERED IN STRATIFIED SHOOT APICES OF GENETIC MOSAICS
996
Herbivory in a Mediterranean forest: browsing impact and plant compensation
997
Herbivory in early Tertiary Arctic forests
998
Herbivory on macro-algae affects colonization of beach-cast algal wrack by detritivores but not its decomposition
999
Herbivory passing the limits
1000
Herbivory responsive C2H2 zinc finger transcription factor protein StZFP2 from potato